Related Experiment Videos

5-Hydroxytryptamine inhibits P2X2 receptor channel pore mutants

K Nakazawa1, Y Ohno

  • 1Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan. nakazawa@nihs.go.jp

Summary

5-Hydroxytryptamine enhances wild-type P2X2 receptor/channel currents but inhibits mutants. This suggests 5-hydroxytryptamine binds to the P2X2 receptor/channel pore, particularly at Thr330 and Asn333 residues.

Related Concept Videos